Chemical Structure (Colistimethate 01)
Colistimethate Injection, Powder, For Solution
Product Images NDC 70594-023
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Colistimethate (NDC 70594-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Colistimethate 02)
This text provides information about colistin base activity measured in mg/mL. It also mentions urine and serum values in adults following the administration of Colistimethate for Injection, either parenterally (IM or IV). Figure 1 likely displays the data related to these values.*
Principal Display Panel (150 mg Vial Carton)
This text describes a medication called Colistimethate for Injection, USP with colistin base activity. It is intended for intramuscular and intravenous use, typically administered in divided doses at specific dose levels depending on the severity of the infection and renal function of the patient. Each vial contains sterile colistimethate sodium equivalent to 150 mg colistin base activity. The storage instructions, usual dosage information, and manufacturing details are provided in the text. It also mentions the importance of referring to the package insert for complete prescribing information and reconstitution directions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
